1. Home
  2. VYGR vs COFS Comparison

VYGR vs COFS Comparison

Compare VYGR & COFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • COFS
  • Stock Information
  • Founded
  • VYGR 2013
  • COFS 1898
  • Country
  • VYGR United States
  • COFS United States
  • Employees
  • VYGR N/A
  • COFS N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • COFS Major Banks
  • Sector
  • VYGR Health Care
  • COFS Finance
  • Exchange
  • VYGR Nasdaq
  • COFS Nasdaq
  • Market Cap
  • VYGR 386.1M
  • COFS 322.9M
  • IPO Year
  • VYGR 2015
  • COFS N/A
  • Fundamental
  • Price
  • VYGR $5.43
  • COFS $36.50
  • Analyst Decision
  • VYGR Strong Buy
  • COFS Strong Buy
  • Analyst Count
  • VYGR 8
  • COFS 1
  • Target Price
  • VYGR $17.00
  • COFS $37.00
  • AVG Volume (30 Days)
  • VYGR 583.2K
  • COFS 35.0K
  • Earning Date
  • VYGR 11-12-2024
  • COFS 10-23-2024
  • Dividend Yield
  • VYGR N/A
  • COFS 3.01%
  • EPS Growth
  • VYGR N/A
  • COFS 5.14
  • EPS
  • VYGR 0.47
  • COFS 3.16
  • Revenue
  • VYGR $163,784,000.00
  • COFS $87,896,000.00
  • Revenue This Year
  • VYGR N/A
  • COFS N/A
  • Revenue Next Year
  • VYGR N/A
  • COFS $77.96
  • P/E Ratio
  • VYGR $11.65
  • COFS $11.32
  • Revenue Growth
  • VYGR 3.40
  • COFS 8.01
  • 52 Week Low
  • VYGR $5.19
  • COFS $21.52
  • 52 Week High
  • VYGR $11.72
  • COFS $37.00
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 34.18
  • COFS 72.31
  • Support Level
  • VYGR $5.19
  • COFS $35.10
  • Resistance Level
  • VYGR $5.59
  • COFS $36.44
  • Average True Range (ATR)
  • VYGR 0.41
  • COFS 0.76
  • MACD
  • VYGR -0.19
  • COFS 0.01
  • Stochastic Oscillator
  • VYGR 10.71
  • COFS 89.25

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About COFS ChoiceOne Financial Services Inc.

ChoiceOne Financial Services Inc is a full-service banking institution. It is engaged in the business of providing personal and business banking solutions, borrowing solutions, and treasury notes and bonds services. The bank's product and services portfolio consist of time, savings and demand deposits, safe deposit services, automated transaction machine services, commercial and consumer loans, commercial lending to business, industry, agricultural, construction, inventory, and real estate categories. Its primary market area is Kent, Muskegon, Newaygo, and Ottawa counties in western Michigan, and Lapeer, Macomb, and St. Clair counties in southeastern Michigan in the communities where the Bank's respective offices are located.

Share on Social Networks: